• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现代时期头颈部鳞状细胞癌患者临床阴性颈部的管理

Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era.

作者信息

Bar Ad Voichita, Chalian Ara

机构信息

Department of Radiation Oncology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.

出版信息

Oral Oncol. 2008 Sep;44(9):817-22. doi: 10.1016/j.oraloncology.2007.12.003. Epub 2008 Mar 6.

DOI:10.1016/j.oraloncology.2007.12.003
PMID:18328776
Abstract

Management of the cervical metastases is of paramount importance in the treatment of patients with head and neck squamous cell carcinoma (HNSCC). Head and neck oncologists continue to debate the appropriate approach of the clinically negative neck among patients with HNSCC. There are three management options: (A) Observation, reserving therapeutic neck dissection for only those patients who subsequently develop metastatic disease in the neck. (B) Staging with reserving definitive treatment for those who are found to have subclinical disease in the neck. Staging may require the use of imaging techniques or "staging" neck dissection. In the latter case a selective neck dissection (SND) is usually recommended, but it is still controversial if this surgical procedure for clinically negative neck is a staging or a therapeutic approach. (C) Elective treatment of the neck using neck dissection, radiation therapy or both. All these strategies may be appropriate, depending on the clinical circumstances and will be discussed in this review.

摘要

在头颈部鳞状细胞癌(HNSCC)患者的治疗中,颈部转移灶的处理至关重要。头颈部肿瘤学家对于HNSCC患者中临床阴性颈部的恰当处理方法仍存在争议。有三种处理方案:(A)观察,仅对那些随后出现颈部转移性疾病的患者进行治疗性颈清扫术。(B)分期,对那些被发现颈部有亚临床疾病的患者保留确定性治疗。分期可能需要使用影像学技术或“分期性”颈清扫术。在后一种情况下,通常推荐选择性颈清扫术(SND),但对于这种针对临床阴性颈部的手术是分期性还是治疗性方法仍存在争议。(C)使用颈清扫术、放射治疗或两者对颈部进行选择性治疗。所有这些策略可能都合适,具体取决于临床情况,本文将对此进行讨论。

相似文献

1
Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era.现代时期头颈部鳞状细胞癌患者临床阴性颈部的管理
Oral Oncol. 2008 Sep;44(9):817-22. doi: 10.1016/j.oraloncology.2007.12.003. Epub 2008 Mar 6.
2
Elective and therapeutic selective neck dissection.选择性颈清扫术(包括择期性和治疗性)。
Oral Oncol. 2006 Jan;42(1):14-25. doi: 10.1016/j.oraloncology.2005.03.009. Epub 2005 Jun 23.
3
[Cervical lymph nodes: surgeon's point of view].[颈部淋巴结:外科医生的观点]
Cancer Radiother. 2014 Oct;18(5-6):549-52. doi: 10.1016/j.canrad.2014.06.020. Epub 2014 Sep 2.
4
Impact of elective neck dissection vs observation on regional recurrence and survival in cN0-staged patients with squamous cell carcinomas of the upper aerodigestive tract.选择性颈部清扫术与观察对cN0期上消化道鳞状细胞癌患者区域复发及生存的影响
Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):650-5. doi: 10.1001/archoto.2012.1026.
5
Management of contralateral N0 neck in tonsillar squamous cell carcinoma.扁桃体鳞状细胞癌对侧N0颈部的处理
Laryngoscope. 2005 Sep;115(9):1672-5. doi: 10.1097/01.mlg.0000184791.68804.0b.
6
Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.选择性颈清扫术(IIA、III型):N0期声门上型和声门型鳞状细胞癌患者全功能性颈清扫术的合理替代方案。
Laryngoscope. 2008 Apr;118(4):676-9. doi: 10.1097/MLG.0b013e31815f6f25.
7
[Selective neck dissection for node-positive necks (N1, N2) in patients with head and neck squamous cell carcinoma].[头颈部鳞状细胞癌患者颈部淋巴结阳性(N1、N2)的选择性颈清扫术]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Sep;43(9):681-5.
8
Head and neck squamous cell carcinoma: sentinel node or selective neck dissection.头颈部鳞状细胞癌:前哨淋巴结或选择性颈部清扫术
Surg Oncol Clin N Am. 2007 Jan;16(1):81-100. doi: 10.1016/j.soc.2006.10.004.
9
[Sentinel node mapping in head and neck squamous cell carcinoma].[头颈部鳞状细胞癌中的前哨淋巴结定位]
Laryngorhinootologie. 2006 Dec;85(12):897-902. doi: 10.1055/s-2006-925293.
10
Comment on "Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era" (Bar Ad V, Chalian A. Oral Oncol 2008;44:817-22).对《现代头颈部鳞状细胞癌患者临床阴性颈部的处理》的评论(Bar Ad V, Chalian A.《口腔肿瘤学》2008年;44卷:817 - 822页)
Oral Oncol. 2009 Feb;45(2):192; author reply 193. doi: 10.1016/j.oraloncology.2008.04.014. Epub 2008 Dec 17.

引用本文的文献

1
Development and validation of a machine learning model to predict the risk of lymph node metastasis in early-stage supraglottic laryngeal cancer.预测早期声门上型喉癌淋巴结转移风险的机器学习模型的开发与验证
Front Oncol. 2025 Jan 29;15:1525414. doi: 10.3389/fonc.2025.1525414. eCollection 2025.
2
A Proposed Method for Cervical Lymph Node Evaluation in Head and Neck Cancer Patients: A Radiological Study.一种用于头颈部癌症患者颈部淋巴结评估的提议方法:一项放射学研究。
J Maxillofac Oral Surg. 2022 Mar;21(1):156-162. doi: 10.1007/s12663-020-01341-y. Epub 2020 Mar 11.
3
Paradoxical Roles of Desmosomal Components in Head and Neck Cancer.
桥粒成分在头颈部癌症中的矛盾作用。
Biomolecules. 2021 Jun 20;11(6):914. doi: 10.3390/biom11060914.
4
[Analysis and management of occult cervical lymph node metastasis of cN0 supraglottic laryngeal carcinoma].cN0声门上型喉癌隐匿性颈淋巴结转移的分析与处理
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Jul;34(7):615-617. doi: 10.13201/j.issn.2096-7993.2020.07.009.
5
Predictors of health-related quality of life in patients treated with neck dissection for head and neck cancer.接受头颈癌颈清扫术治疗患者健康相关生活质量的预测因素
Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4183-4193. doi: 10.1007/s00405-017-4754-x. Epub 2017 Sep 22.
6
The impact of tissue glue in wound healing of head and neck patients undergoing neck dissection.组织胶水对接受颈部解剖的头颈患者伤口愈合的影响。
Eur Arch Otorhinolaryngol. 2016 Jan;273(1):245-50. doi: 10.1007/s00405-015-3709-3. Epub 2015 Jul 9.
7
Incidence and outcome for patients with occult lymph node involvement in T1 and T2 oral squamous cell carcinoma: a prospective study.T1和T2期口腔鳞状细胞癌隐匿性淋巴结受累患者的发病率及预后:一项前瞻性研究。
BMC Cancer. 2014 May 20;14:346. doi: 10.1186/1471-2407-14-346.
8
DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays.DSG3 作为一种生物标志物,用于使用纳米结构免疫阵列对口腔癌隐匿性淋巴结转移进行超灵敏检测。
Oral Oncol. 2013 Feb;49(2):93-101. doi: 10.1016/j.oraloncology.2012.08.001. Epub 2012 Sep 23.